Amy E Rothberg, MD, DABOM
Manage Your Profile
About
Amy E. Rothberg, MD, DABOM is Clinical Professor of Medicine in the Division of Metabolism, Endocrinology and Diabetes and Professor of Nutritional Sciences in the School of Public Health at the University of Michigan. She is the Director of the University of Michigan Weight Management Program, a 2-year intensive behavioral and lifestyle program onto which there is a multifaceted research program in which patients undergo extensive baseline and interval phenotyping to identify the factors that predict successful and cost-effective long-term weight loss. Her primary research is funded by the NIH/NIDDK. Her work encompasses three major research foci: The first is on the impact of the interventions on insulin secretion, insulin action, long-term glycemia, the development of complications and comorbidities, health-related quality-of-life, and cost. The second is on the behavioral and biological determinants of weight loss and weight loss maintenance. The third is scalability of her program through telehealth and the internet and the impact on the processes and outcomes of care.
Qualifications
-
ResidencyUniversity of Michigan, Internal Medicine, Ann Arbor, United States
Residency
Center Memberships
-
Center MemberCaswell Diabetes Institute
Research Overview
- Determining factors that predict successful and cost-effective long-term weight loss
- Assessing the neurobiopsychosocial adaptations that occur with weight loss
- Evaluating implementation of a model of intensive behavioral therapy from sub-speciality care into primary care
- Impact of weight loss on health related quality of life
- Effects of intensive lifestyle intervention on reproductive, maternal and fetal outcomes
Recent Publications
-
Melville N. 2026 Apr 9;Additional ScholarshipJCEM study quoted in Medscape article, "Concerns Continue Over Proposed New Obesity Definitions"
-
Rothberg A. 2026 Apr 9; Pathophysiology of Disease: An Introduction to Clinical Medicine,ChapterObesity and Metabolic Disease
-
Rothberg A. 2026 Apr 9; Pathophysiology of Disease: An Introduction to Clinical Medicine,ChapterObesity and Metabolic Disease
-
Oshman L, Runyon A, Vicenzi Bal A, Arizaca-Dileo P, Sen A, Othman A, Gabison J, Rothberg A, Kraftson A, Griauzde DH, Fendrick AM. Obesity Pillars, 2026 Jul 20; 19 (September 2026):Journal ArticleA survey of primary care physicians' views on supporting patients who lose insurance coverage for Glucagon-Like Peptide-1-based drugs for weight management
-
Larkin M. 2026 Aug 7;Additional ScholarshipQuoted in MedScape article: "Retatrutide Expanded Access Draws Mixed Clinician Views"
-
Louis P. 2026 Aug 7;Additional ScholarshipQuoted in Forbes article, "Does Semaglutide Increase Your Metabolism? What Experts Say"
-
Diep W. 2026 Aug 7;Additional ScholarshipQuoted in MLive article, "What GLP-1 users should know during Ann Arbor’s heat wave"
-
Chen E. 2026 Aug 7;Additional ScholarshipQuoted in Stat Plus article, "Telemedicine company touted by Novo Nordisk stressed profits over patient safety, ex-workers say"
Featured News & Stories
New Findings on Obesity Identification by BMI Without Diagnosis